Journal Article

Extraction of Benzoylecgonine from Urine Specimens with Cerex Polycrom™ Clin II Solid-Phase Extraction Columns and the Speedisk™ Pressure Processor*

Judith A. Kuhnle, Melissa Churley, Shiralen Y. Kawasaki, Timothy P. Lyons and Mark R. Bruins

in Journal of Analytical Toxicology

Volume 25, issue 7, pages 616-620
Published in print October 2001 | ISSN: 0146-4760
Published online October 2001 | e-ISSN: 1945-2403 | DOI: http://dx.doi.org/10.1093/jat/25.7.616
Extraction of Benzoylecgonine from Urine Specimens with Cerex Polycrom™ Clin II Solid-Phase Extraction Columns and the Speedisk™ Pressure Processor*

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

Benzoylecgonine (BZE) extraction from urine was explored using Cerex Polycrom Clin II solid-phase extraction (SPE) columns and the Speedisk 48 Pressure Processor as an alternative to the Prep™1 automated sample processor and XTRX™ Type RP/W columns. Linearity for urine standards extracted using the Cerex-Speedisk method ranged from 20 to 3000 ng/mL. The mean recovery at the 100-ng/mL cutoff for three lots of columns was 92%. The mean of the within-run means for three batches, which had coefficients of variations of 1.8% or less, was 101.3 ng/mL at the lO0-ng/mL cutoff level. Forty-six specimens known to contain BZE were analyzed by both the Prep1-Type RP/W and Cerex-Speedisk methods. The correlation for specimen BZE concentrations between the two methods gave an r2 of 0.9999 and a slope of 1.03. The Cerex-Speedisk system is an inexpensive alternative to the Prep1-Type RP/W system. It is less costly, requires little maintenance, has a small footprint, is hood compatible, and can process four times the number of specimens in a given time.

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.